Xanthohumol as an Adjuvant Therapy in Critically Ill COVID-19 Patients

NCT05463393 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

SUSPENDED

Status

50

Enrollment

OTHER

Sponsor class

Stopped We are waiting for the additional founds.

Conditions

COVID-19 Respiratory Infection

Interventions

BIOLOGICAL: Xanthohumol - prenylated chalcone extracted from female inflorescences of hop cones (Humulus lupus). Hop-RXn™, BioActive-Tech Ltd, Lublin, Poland; http://xanthohumol.com.pl/

Sponsor

Medical University of Lublin